During expiration the flows required to close the Volumatic valve were slightly higher than those required to open the valve, but lie still in a range easily achievable by infants. The flows required to close the Nebuhaler valve were significantly higher than those required to close the Volumatic valve. In the vertical position the expiratory flows averaged 73.9 ml/second (range 69-8-81*5 ml/second) for the Nebuhaler and 24-3 ml/second (range 11-7-31-2 ml/second) for the Volumatic. These flows required for valve closure 
expiratory flow in normal infants (5 to 11 months of age) are 70 ml/second.5 During most of expiration the flow is likely to be considerably less, especially in infants with obstructive airway diseases. Infants with expiratory flow limitation during tidal breathing can not increase expiratory flows without increasing lung volume. Failure to close the spacer valve exposes the infant to the risk of rebreathing.
The intradevice and interdevice coefficients of variation for both types of spacer devices are acceptable. The higher coefficients of variation found during expiration in the Volumatic spacer device than found for Nebuhaler are interesting but of no clinical importance. Thus the intradevice or interdevice variability is not an additional factor to be considered when using airspacers in infancy.
Although up to 100 activations of a metered dose inhaler did not result in an increase in the pressure or flow required to open the spacer valve, prolonged use without adequate cleaning could result in the valve becoming 'sticky', thus requiring greater pressures and flows to operate the valve. Furthermore, the simulated inspiration and expiration in the present study were performed using room air. It is possible that humid expired air could cause the valve to become 'sticky'. On histological examination by two independent pathologists no evidence of an androgen secreting tumour was found, and both ovaries had a polycystic appearance.
Immediately after operation the plasma testosterone concentration fell to 2-6 nmol/l, but then rose again over the next few months. High dose Polycystic ovary syndrome in a virilised, premenarcheal girl 1309 was 4*9 nmol/l. Ovulation and regular menstruation were induced by treatment with clomiphene.
More recently, Rao et al reported a 12 year old girl with progressive hirsutism of nine months' duration.5 This patient was also premenarcheal with clinical signs of virilisation. Her plasma testosterone concentrations were initially measured on three occasions as being between 4*8 and 9-3 nmol/l. Both ovaries were enlarged on exploratory laparotomy, and bilateral wedge resections of the ovaries were carried out, which showed histological evidence of polycystic ovary syndrome but no tumour. In this patient the testosterone concentrations did not fall after operation, and she was treated successfully with an oral contraceptive.
Thirdly, polycystic ovary syndrome is usually characterised by some enlargement of the ovaries, but is rarely associated with large cysts. The patients in the reports above all had bilaterally moderately enlarged ovaries, but none had individual cysts of the size seen in our patient. This feature also suggests the possibility of associated malignancy, which was not found.
The pathophysiology of polycystic ovary syndrome is still not clearly understood. There are three main approaches to its treatment. Ovulation may be induced by various drugs including clomiphene citrate, human chorionic gonadotrophin, and pure follicle stimulating hormone; the older therapeutic approach of ovarian wedge resection is used much less often today. Antiandrogenic drugs such as cyproterone acetate may be used to reverse the clinical features of masculinisation. Low dose oral contraceptives suppress gonadotrophin secretion and reduce ovarian secretion of androgen; they also reduce the adrenal production of steroids. In this patient an oral contraceptive successfully suppressed both testosterone and gonadotrophin concentrations.
In conclusion, this case and a few previously reported show that isolated polycystic ovary syndrome can be found in virilised premenarcheal girls. In such patients, however, an adrenal source of excess androgen or a virilising tumour of the ovary must be excluded. Her skin consisted of thick, yellow, leathery plaques separated by deep red cracks. There was ectropion of the eyelids and eclabion of the mouth. The ears were flattened and bound to the side of the head. The digits of the hands and feet were flexed and bound together by tight membranes. Examination of a skin biopsy by light and electron microscopy showed changes consistent with the clinical diagnosis of a harlequin fetus.
The baby was nursed in an humidified incubator and fluids were administered via an umbilical artery 
